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Transient folding intermediates and/or partially un-
folded equilibrium states are thought to play a key
role in the formation of protein aggregates. However,
there is only indirect evidence linking accumulation
of folding intermediates to aggregation, and the
underlying mechanism remains to be elucidated.
Here, we show that a partially unfolded state of the
prion protein accumulates both as a stable equilib-
rium state at acidic pH (A-state) and as a late folding
intermediate. With a time resolution of approximately
60 ms, we systematically studied the kinetics of
folding and unfolding, starting from various initial
conditions including the U-, N-, and A-states. Quan-
titative modeling showed that the observed kinetic
data are completely consistent with a sequential
four-state mechanism where the A-state is a late
folding intermediate. Combined with previous evi-
dence linking A-state accumulation to aggregation,
the results indicate that this native-like state serves
as a branching point between the folding and aggre-
gation pathways.
INTRODUCTION
Prion diseases are a group of fatal neurodegenerative diseases
affecting humans and animals that are linked to the misfolding
and aggregation of the prion protein (PrP) (Prusiner, 1982,
1998). According to the ‘‘protein-only’’ hypothesis, conversion
of the cellular prion protein (PrPC) to its pathogenic isoform
(PrPSc) is a crucial event in the pathogenesis of prion diseases
(Prusiner, 1982, 1998). PrPC contains three a helices, helix 1
(H1), helix 2 (H2), and helix 3 (H3), as well as a small b sheet
(Riek et al., 1996). H2 and H3 are connected by a disulfide bridge
between Cys179 and Cys214. In contrast, PrPSc is mainly
composed of b-sheet structures, as revealed by Fourier-trans-
form infrared spectroscopy (Pan et al., 1993), and it has been
reported that the infectious particles in prion diseases are oligo-Structure 23, 1735–17mers (Masel et al., 2005; Silveira et al., 2005). Thus, elucidating
the mechanism by which the a helices of PrPC become the b
sheets of PrPSc, a process termed b-conversion, as well as the
structural basis for oligomerization, is critical for understanding
and controlling prion pathogenesis.
It is well known that acidic pH favors transformation of PrP into
a variety of b-rich oligomers (Hornemann and Glockshuber,
1998; Jain and Udgaonkar, 2008; Morillas et al., 2001; Rezaei
et al., 2002; Swietnicki et al., 1997). We recently reported the for-
mation of an acid-induced partially unfolded state characterized
by the molten globule-like structure (A-state) just prior to the for-
mation of b-rich oligomers (Honda et al., 2014). The initial fraction
of PrP in the A-state was strongly correlated with the rate of olig-
omerization at pH 2–5, suggesting that the A-state is directly
involved in the oligomerization pathway. Previously, a folding in-
termediate state (I-state) was implicated as a precursor in the
pathogenic conversion process because this state was stabi-
lized by mutations observed in inherited prion diseases (Apetri
et al., 2004, 2006). However, it is unclear whether and how the
I- and A-states are related, and how the oligomerization pathway
is connected to the folding pathway (Chiti et al., 2002; Jahn and
Radford, 2005). The kinetic folding intermediates of several
proteins have been shown to be structurally analogous to
non-native equilibrium forms with features of a molten globule
(Kuwajima, 1989; Ptitsyn et al., 1990), as demonstrated by tech-
niques such as pulsed hydrogen/deuterium exchange, small-
angle X-ray scattering, and time-resolved nuclear magnetic
resonance (NMR) (Arai et al., 2002; Eliezer et al., 1995; Hughson
et al., 1990; Jeng et al., 1990; Jennings and Wright, 1993;
Raschke andMarqusee, 1997). Recent work on b2-microglobulin
also demonstrated that formation of a folding intermediate con-
taining a non-native prolyl cis-trans isomer precedes aggregate
formation (Jahn et al., 2006; Mukaiyama et al., 2013a, 2013b).
Although the folding mechanism of the PrP is significantly
different to that of b2-microglobulin, it is essential to clarify the
role of the A-state as a critical intermediate in both the folding re-
action and oligomer formation.
To investigate the kinetic role of the A-state, we observed the
kinetics of folding and unfolding of PrP using various initial
conditions favoring population of the native (N-), unfolded (U-),
and A-states. An engineered tryptophan (Trp218) served as a
probe for monitoring the conformational changes associated42, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1735
Figure 1. Structural and Thermodynamic Characteristics of the A-State
(A–C) Far-UV CD (A), near-UV CD (B), and Trp-fluorescence (C) spectra for the N-state at pH 4.5 (red), the A-state at pH 2.0 (blue), and the U-state at pH 2.0 with
3 M urea (dotted black line), respectively.
(D) Thermal unfolding of the N-state at pH 4.5 (red) and the A-state at pH 2.0 (blue) monitored via the change in mean residue ellipticity at 222 nm. The solid
lines represent least-squared fits to van’t Hoff’s equation, where the equilibrium constant between two states is described by the exponential of (DHwfDST)/RT.
DHwf (kcal/mol) and DS (cal/mol$K)] of N- and A-states are (42 ± 4 and 122 ± 11) and (16 ± 1 and 48 ± 2), respectively.
(E) 13Ca-chemical shift indices of the N-state at pH 4.5 (red) and the A-state at pH 2.0 (blue).
(F) 13Ca-chemical shift indices of the A-state plotted onto the 3D structure of mouse PrP(121–231) (PDB: 1AG2). The unassigned residues are shown in gray.with folding and unfolding on the submillisecond timescale,
using an ultra-rapid continuous-flow mixing technique with a
dead time of approximately 60 ms (Roder et al., 2004, 2006;
Shastry et al., 1998). Our results indicate that the A-state is
clearly distinct from the I-state. Quantitative analysis of the
folding and unfolding kinetics suggested that the A-state cor-
responds to a late, native-like intermediate in the folding of
PrP, and that the A-state is a key intermediate located at a
bifurcation point between the monomeric folding and oligomeri-
zation aggregation pathways.
RESULTS
Structural and Thermodynamic Characteristics of the
A-State
As in previous kinetic studies on the human PrP fragment 90–231
(Apetri et al., 2006; Apetri and Surewicz, 2002), we worked with a
W145H/Y218Wmutant of the highly homologousmouse protein,
which contains a single Trp residue in the folded domain. By
lowering the pH from 4.5 to 2.0, the native state of PrP (N-state)
was transformed into an acid-induced partially unfolded state
(A-state), which is characterized by a moderate change in sec-
ondary structure (Figure 1A) and a partially disrupted tertiary
structure (Figure 1B), as revealed by far- and near-UV circular
dichroism (CD), respectively. The Trp-fluorescence emission
spectrum of the A-state coincides with that of the N-state (Fig-1736 Structure 23, 1735–1742, September 1, 2015 ª2015 Elsevier Lture 1C), indicating that the A-state maintains native-like tertiary
structure in the region surrounding the tryptophan residue
(see also Figure 1F). The A-state is thermodynamically charac-
terized by a low enthalpy and entropy change upon unfolding
(16 kcal/mol and 48 cal/mol$K for DHwf and DS, respectively)
compared with the N-state (42 kcal/mol and 122 cal/mol$K for
DHwf and DS, respectively) (Figure 1D). The
13Ca-chemical shift
indices at pH 2.0 obtained by sequentially assigning the peaks in
the NMR spectrum (Figure S1) exhibit values near zero in the S1-
H1-H2 segment (amino acid residues 129–160) (Figures 1E and
1F). This shows that this segment is almost completely unfolded
in the A-state (Wishart et al., 1992), which is consistent with pre-
vious hydrogen/deuterium exchange results (Honda et al., 2014).
In contrast, most of the H2-H3 segment remains unassigned due
to severe line broadening (Figure S1), which suggests that this
region fluctuates between some folded and unfolded structures
on the millisecond timescale. Thus, the N-terminal S1-H1-S2
segment appears to be extensively disordered or completely
unfolded in the A-state, while the C-terminal H2-H3 segment re-
tains a marginally stable structure (Honda et al., 2014).
Accumulation of a Kinetic Intermediate State during
Folding
We examined the folding and unfolding kinetics of the W145H/
Y218W variant of mouse PrP(90–231) at pH 4.5 in the pres-
ence of various concentrations of urea (0–7.0 M) starting fromd All rights reserved
Figure 2. Folding and Unfolding Kinetics
(A) Representative kinetic traces for folding of mouse PrP at pH 4.5 in the presence of 0.5–2.5 M urea, starting from conditions favoring the U-state (pH 2.0,
3.0 M urea).
(B) Representative traces for unfolding at pH 4.5 in the presence of 5.0–7.0 M urea, starting from conditions favoring the N-state (pH 4.8, 2.0 M urea). The solid
lines represent least-squared fits to a single exponential function.
(C) Chevron plots in the absence (filled circles) or presence (empty squares) of 0.17MNa2SO4. The solid and dotted lines represent curves generated by assuming
a three-state scheme (Table S1).the U-state at pH 2.0 and 3.0 M urea, as well as from the N-state
at pH 4.8 and 2.0 M urea. To resolve the kinetics of folding of
PrP, which occurs on the millisecond timescale or faster, even
at 5C (Apetri et al., 2006; Apetri and Surewicz, 2002), we com-
bined ultra-rapid mixing (Shastry et al., 1998) with conventional
stopped-flow measurements. The refolding and unfolding time
courses are both well described by a single exponential function
over the time range from approximately 100 ms to 30 ms (Figures
2A and 2B). However, the log(rate) versus urea concentration
(chevron) plot strongly deviates from a linear dependence on
urea concentration below approximately 2 M (Figure 2C). This
non-linearity, known as ‘‘rollover,’’ is generally attributed to the
accumulation of a folding intermediate within the dead time.
Furthermore, the rollover was more prominent in the presence
of 0.17 M Na2SO4 (Figure 2C and Table S1), which generally sta-
bilizes folding intermediates (Gorski et al., 2001; Jahn et al.,
2006; Khorasanizadeh et al., 1996). Thus, an early kinetic inter-
mediate, which we refer to as the I-state, accumulates during
the refolding of PrP from strongly denaturing conditions.
Unfortunately, without direct observation of the fast U/I tran-
sition, we cannot determine whether the I-state lies on a direct
path from U to N (Capaldi et al., 2001). However, the main pur-
pose of this study is to elucidate the kinetic role of the A-state,
and the following kinetic analysis was found to be independent
of the kinetic role of the I-state (data not shown). Therefore,
for simplicity, we assume that the I-state is an on-pathway
intermediate.
The Folding/Unfolding Kinetics of the A-State
Next, we examined the folding/unfolding kinetics starting fromA-
state conditions at pH 2.0. Final conditions were the same as
those in experiments starting from the N- and U-states (pH 4.5
in the presence of 0–7M urea). It should be noted that the folding
kinetics of the A-state below 2.0 M urea is not accompanied by a
prominent fluorescence change (Figure 3A), in contrast to the
folding experiment shown in Figure 2A, indicating that the A-
state does not correspond to the kinetic intermediate I. In addi-
tion, the A-state can probably reach the N-state without going
through the I-state. Otherwise, its folding rate would be limited
by the major kinetic barrier of the I/N transition and we shouldStructure 23, 1735–17observe a phase with a rate constant of approximately 3,000 s1
(Figures 2A and 2C). This also indicates that the A-state lies on
the native side of the major kinetic barrier for the I/N folding
transition. Interestingly, the folding/unfolding kinetics of the A-
state above 3.0 M urea exhibit two distinct phases with rate con-
stants of approximately 5,000 and 500 s1, respectively (Figures
3A and 3B). The fast phase was not observed in Figure 2B, while
the slow phase closely matches that observed in the previous
unfolding experiments (Figure 3B). This indicates that the A-state
partially shares a common unfolding pathway with the N-state.
Evidence for the A-State as a Late Folding Intermediate
Next, we investigated which folding scheme best describes
the folding/unfolding kinetics of the A-state. As we have shown
that A and I are distinct states (Figures 3A and 3B), the min-
imal mechanism is a four-state scheme. We initially tested
different linear four-state schemes, such as U4I4A4N or
U4A4I4N. Theoretically, there are 16 distinct linear schemes
(Figure S2), but 11 of them can be ruled out by assuming that
the I-state is an on-pathway intermediate (black in Figure S2).
Furthermore, based on the folding/unfolding kinetics of the
A-state (Figures 3A and 3B), we were able to place the A-state
beyond the kinetic barrier of the I/N transition, which rules out
threeof thefive remainingschemes.Asa result, only twoschemes
remained: U4I4A4N, where the A-state corresponds to a late
folding intermediate, and U4I4N4A, where the A-state corre-
sponds to an off-pathway intermediate (blue in Figure S2). The
latter scheme, however, can also be ruled out by taking into ac-
count the amplitudeplot (Figure 3C). In theU4I4N4A scheme,
the fast and slow phases observed during the unfolding of the
A-state are interpreted as the A/N andN/I transitions, respec-
tively. Therefore, a major fraction of PrP is expected to form the
N-state just after the fast phase.However, the fluorescence inten-
sity just after the fast phase, which is approximately described by
the sumof the fluorescence intensity at infinity and the kinetic am-
plitudes of the slow phase, FN + As (downward triangles in Fig-
ure 3C), was much higher than the fluorescence of the N-state
or the native baseline (inset, Figure 3C). On the other hand,
the U4I4A4N scheme fully reproduces the folding/unfolding
kinetics of the A-state, including the rate constants and kinetic42, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1737
Figure 3. Kinetics of Folding and Unfolding
of the A-State
(A) Representative folding/unfolding kinetic traces
at pH 4.5 in the presence of 0–7.0 M urea starting
from conditions favoring the A-state (pH 2.0). The
solid lines represent least-squared fits to a double
exponential function:
fðtÞ=fðAÞ=Af expð  lf tÞ+As expð  lstÞ+ fN:
(Equation 1)
(B) Chevron plot. Filled circles and empty triangles
represent lf and ls in Equation 1, respectively.
For comparison, the apparent rate constants in
Figure 2C are shown as empty squares. The solid
curve represents the curve reproduced by
assuming the U4I4A4N scheme (Table 1).
(C) Amplitude plot. Circles, downward triangles,
and upward triangles represent fN, (fN + As), and
(fN + As + Af) from Equation 1, respectively. The
solid curve represents the curve reproduced by
assuming the U4I4A4N scheme (Table 1).
The fluorescence intensity of the U-, I-, A-, and
N-states at 0 M urea is 1.01, 1.30, 1.05, and 1.05,
respectively. The slope against urea concentration
(M1) of the U-, I-, A-, and N-states is 0.23, 0.10,
0.05, and 0.05, respectively. (Inset) Equilibrium urea titration curve obtained under the same conditions. The dotted line represents the baseline N-state.
(D) Free-energy diagram. The activation free energies of the transitions, Ea = RTln(k/A0), were calculated from kIA and kAN (Table 1) values using a pre-exponential
factor A0 = 10
6 (s1). The double dagger symbols represent the transition states.
Bars represent fitting errors (SD).amplitudes (Figures 3B and 3C, Table 1). This analysis assumed
that the A-state shares common fluorescence properties with
the N-state, namely 1.05 of the fluorescence intensity at 0 M
urea and 0.05 of the slope versus urea concentration (Figure 3C),
consistent with thewell-organized tertiary structure of the A-state
(Figures 1B and 1C). Hence, we concluded that the PrP folding is
described by the U4I4A4N scheme, i.e., the A-state corre-
sponds to a late folding intermediate.
The fact that we observed only one intermediate state in our
first set of folding/unfolding experiments (Figures 2A–2C) is not
inconsistent with this conclusion, since the four-state scheme
predicts only one exponential phase with measurable amplitude
within the approximately 100-ms time resolution of our measure-
ments, as observed (Figures 4A and 4B). A three-state scheme
can also reproduce the chevron plot (data not shown). Since
the A-state lies beyond the rate-limiting step in both folding
and unfolding experiments (Table 1), its maximum population
is only 23% and 11% during folding and unfolding, respectively.
The fluorescence properties of the A-state closely correspond to
those of the N- state (Table 1), which further hampered detection
of the A-state. Thus, the four-state scheme is fully consistent
with all our kinetic data, including those in Figures 2A–2C.Table 1. Kinetic Parameters for the Four-State Scheme
(U4I4A4N)
KUI
a (MUI
b) kIA
c (mIA
d) kAI (mAI) kAN (mAN) kNA (mNA)
29 (0.80) 4,176 (0.03) 1,298 (0.08) 8,222 (0.14) 331 (0.07)
aEquilibrium constant.
bm value (kcal/mol$M).
cElementary rate constant (s1).
dKinetic m value (kcal/mol$M).
1738 Structure 23, 1735–1742, September 1, 2015 ª2015 Elsevier LtIt should be noted that we cannot definitively rule out
more complicated schemes, such as five-state schemes and
branched four-state schemes (Radford et al., 1992). Pulsed
hydrogen/deuterium exchange and/or the quenched-flow ex-
periments would be beneficial to rule out these more compli-
cated schemes, but the short lifetime of the kinetic intermediate
states (Figures 2A and 3A) and the high tendency of PrP to
aggregate at alkaline pH make such studies very challenging.
However, the quality of the fits in Figure 3 indicates that the
U4I4A4N scheme is the simplest mechanism that describes
the folding/unfolding kinetics of mouse PrP.
DISCUSSION
In this study we investigated the kinetic role of the A-state of
mouse PrP, an acid-induced partially unfolded state with some
of the characteristics of a molten globule recently identified as
a possible pre-oligomeric state (Honda et al., 2014). By exam-
ining the kinetics of folding and unfolding under various initial
and final conditions, we showed that the A-state corresponds
to a late folding intermediate, suggesting that oligomerization
starts from this partially unfolded state, which contains a
native-like H2-H3 hairpin (Figure 5). Under physiological condi-
tions, late folding intermediates are expected to be more highly
populated than early intermediates. They are, therefore, more
likely to lead to formation of pathogenic oligomers (Brockwell
and Radford, 2007). Thus, the A-state may be a key intermediate
in both folding and self-association, giving rise to the formation
of b-rich oligomers.
A number of studies have demonstrated that lowering
pH increases the rate constant of b-rich oligomer formation
(Hornemann and Glockshuber, 1998; Jain and Udgaonkar,d All rights reserved
Figure 4. Folding and Unfolding Kinetics
Predicted by the U4I4A4N Scheme
The folding kinetics at 0 M urea (A) and the un-
folding kinetics at 6 M urea (B) were calculated
by solving the four-state mechanism using the
parameters in Table 1 and the legend of Figure 3.
The upper and lower panels represent the time-
dependent fluorescence change and the fraction
of each state, respectively.2008; Morillas et al., 2001; Rezaei et al., 2002; Swietnicki et al.,
1997). For instance, for mouse PrP we observed rates of
0.0389 min1 and 15.7 min1 at pH 4.5 and 2.0, respectively
(Honda et al., 2014). Acceleration of the aggregation process
at acidic pH may be attributed to an increase in the equilibrium
population of the A-state. From the kinetic parameters of PrP
folding presented in this report, the equilibrium population of
the A-state at pH 4.5 was calculated to be 3.8% (Table 1),
whereas at pH 2.0 almost 100% of the protein forms the A-state.
This correlation between aggregation rate and A-form popula-
tion is consistent with the hypothesis that the A-state is located
at the branching point between folding and aggregation.
Since there is no evidence for infectivity of the b-rich PrP
oligomers formed at acidic pH, it remains unclear whether or
not the A-state is actually involved in the pathogenic conversion
into PrPSc. However, recent studies have revealed that muta-
tions linked to prion diseases destabilize H1 and accelerate the
formation of b-rich oligomers (Singh and Udgaonkar, 2015).
They further suggest that the RNA and POPG (1-palmitoyl-2-Figure 5. A Schematic Free-Energy Landscape for Folding and
Oligomerization of PrP
In this scheme, unfolded PrPC (U) folds into the N structure via two interme-
diate states: the I- and A-states (black arrow). Oligomerization and aggregation
starts from a late folding intermediate, the A-state (red arrow). The A-state is a
key intermediate fromwhich the folding and oligomerization pathways diverge.
F, Q1, and Q2 represent the Gibbs free energy, the first reaction coordinate,
and the second reaction coordinate, respectively.
Structure 23, 1735–17oleoylphosphatidylglycerol) molecules that facilitate the patho-
genic conversion (Wang et al., 2010) also destabilize H1 (Miller
et al., 2013). The conformational characteristics of the A-state
suggest that partial unfolding of the S1-H1-S2 regionmay trigger
further conformational changes at theC terminus of H2 and in the
H2-H3 loop region (Kuwata et al., 2007; Miller et al., 2013; Singh
et al., 2014), which facilitate intermolecular interactions by
exposing the hydrophobic residues at the interface between
the H2 and H3 helices. Furthermore, anti-prion compounds
(‘‘medical chaperones’’) intercalate between the H1 and H2-H3
loops and stabilize PrP (Kamatari et al., 2013; Kuwata et al.,
2007). Thus, H1 destabilization and formation of the A-state (Fig-
ure 1E) may be related to the pathogenesis of prion diseases.
Since the initial process of b-rich oligomer formation is similar
to that of PrPSc formation, it is reasonable to assume that the
A-state corresponds to the initial monomeric precursor in the
pathogenic conversion or PrP* (Cohen et al., 1994).
In a recent ultra-fast mixing study of the folding/unfolding
kinetics of sheep PrP, Chen et al. (2011) observed accumulation
of an intermediate state during unfolding that corresponds to the
A-state observed in the present study. This unfolding intermedi-
ate was stabilized bymutations related to inherited prion disease
(Chen et al., 2011), suggesting that the kinetic intermediate
detected is involved in pathogenesis. This sheep PrP unfolding
intermediate is characterized by native-like fluorescence proper-
ties and compactness, which is consistent with our current
observations (Figure 1C and Table 1), as well as the structural
characteristics observed for the equilibrium A-state of mouse
PrP (Honda et al., 2014).
Previous kinetic studies identified an early intermediate in the
folding of human PrP (I-state in our terminology) that was pro-
posed to act as a monomeric precursor to b-rich oligomers.
This proposal was based on the fact that the intermediate is sta-
bilized by mutations linked to prion diseases (Apetri et al., 2004,
2006) and by conditions known to promote aggregation, such as
low pH (Apetri et al., 2006; Apetri and Surewicz, 2002). In terms
of its kinetic and structural properties, the I-state is clearly
distinct from the A-state (Figures 3A and 3B). Given the high de-
gree of sequence conservation among the three PrP variants and
the similarity of the chevron plots for the rate-limiting folding/un-
folding phases (Apetri et al., 2006; Chen et al., 2011), it is
likely that they share a common folding mechanism, such as
the sequential four-state mechanism shown in Figure 5. The
observed species-dependent differences in kinetic behavior on
the submillisecond timescale can be explained in terms of rela-
tively subtle changes in the free-energy profiles among the three42, September 1, 2015 ª2015 Elsevier Ltd All rights reserved 1739
PrP variants (cf. Figure 3D). For example, the fact that the fast
phase seen during the unfolding of mouse and sheep PrPs is ab-
sent during the unfolding of human PrP can be explained by a
modest shift in the relative free energies of the two barriers, re-
sulting in a decrease in transient accumulation of the A-state.
By modeling the folding/unfolding kinetics of mouse PrP using
alternative kinetic schemes, we were able to show that the
A-state lies on a direct path from the unfolded ensemble to the
N-state (Figure 5). Combined with the structural properties of
the A-state (Figures 1E and 1F), this finding implies that during
the folding of mouse PrP, formation of the H2-H3 helical hairpin
precedes structure acquisition in other regions, including H1 and
the small b sheet. This conclusion is consistent with the relatively
high hydrophobicity of the H2-H3 segment, as well as the
presence of a disulfide bond connecting H2 and H3. A similar
scenario was proposed for human PrP, based on temperature
jump experiments coupled with F-value analyses, which sug-
gested that the hydrophobic core of the H2-H3 segment is
formed during the rate-limiting step in folding (Hart et al., 2009).
EXPERIMENTAL PROCEDURES
Protein Preparation
A plasmid encoding mouse PrP, amino acid residues 90–231 (mouse PrP(90–
231)), with an N-terminal 63 His tag, was prepared according to a previously
reported protocol (Kuwata et al., 2007). Two mutations (W145H/Y218W) were
introduced into mouse PrP(90–231) utilizing the PrimeSTAR Mutagenesis
Basal Kit (Takara Bio). Mouse PrP(90–231,W145H/Y218W) was expressed
and purified as previously described (Kuwata et al., 2007).
Equilibrium Measurements
Solutions of mouse PrP(90–231,W145H/Y218W) were prepared under N-state
(pH 4.5, 20 mM sodium acetate), A-state (pH 2.0, 20 mM glycine-HCl),
and U-state (pH 2.0, 20 mM Gly-HCl, 3 M urea) conditions. The protein
concentrations were 10, 70, and 10 mM for far-UV CD, near-UV CD, and fluo-
rescence measurements, respectively. CD spectra were acquired at 20C ac-
cording to a previously described protocol (Honda et al., 2014). Fluorescence
emission spectra were acquired on an RF-5300PC spectrofluorophotometer
(Shimadzu) at 20C using an excitation wavelength of 298 nm.
Thermal unfolding of the N- or A-state wasmonitored by the change of mean
residue ellipticity at 222 nm by increasing the temperature up to 95C at a rate
of 2C$min1. More than 90% of the mean residue ellipticity was recovered
after the thermal denaturation experiment (data not shown).
For NMR studies of the A-state, 13C,15N uniformly labeled mouse PrP(90–
231,W145H/Y218W) was dissolved with the A-state buffer containing 5%
D2O to a final concentration of 0.5 mM, and a series of 3D NMR spectra
(1H-15N HSQC, HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCBCA, and
HN(CO)CBCA) were acquired. A relatively higher temperature, 32C, at which
approximately 80% of the secondary structure of A-state was retained, was
utilized to improve the quality of the NMR spectra (Eliezer et al., 1997) (Fig-
ure 1D). The NMR peaks were assigned by the sequential method (Ikura
et al., 1990; Kay et al., 1990) using NMRpipe (Delaglio et al., 1995) and KUJIRA
(Kobayashi et al., 2007) software. Secondary chemical shifts were calculated
by subtracting the chemical shifts of the NMR peaks from those of random
coils that were predicted using a freely available program coded by SBiNLab
(Kjaergaard et al., 2011). For NMR studies of the N-state, mouse PrP(90–231,
W145H/Y218W) was dissolved in native buffer containing 5% of D2O to a final
concentration of 0.5 mM. A series of 3D NMR spectra (1H-15N HSQC, HNCO,
HN(CA)CO, HNCA, and HN(CO)CA) were acquired at 12C and analyzed as
described above.
Kinetic Measurements and Modeling
The kinetics of folding and unfolding starting from various conditions that favor
the N- (pH 4.8, 20 mM sodium acetate, 2 M urea), U- (pH 2.0, 20 mM Gly-HCl,
3 M urea), and A-states (pH 2.0, 20 mM Gly-HCl) were examined at 5C.1740 Structure 23, 1735–1742, September 1, 2015 ª2015 Elsevier LtFolding/unfolding was initiated by mixing the initial solutions with a folding/un-
folding buffer (pH approximately 4.5, 50mM sodium acetate with 0–7M urea in
the presence or absence of 0.2MNa2SO4) using amixing ratio of 1:5. This pro-
cedure allowed us to observe the refolding/unfolding kinetics at pH 4.5 as a
function of urea concentration. The kinetics were monitored via the change
in fluorescence at 308–420 nm (excitation at 297 nm) using both the
stopped-flow and ultra-rapid mixing instruments (Roder et al., 2004, 2006;
Shastry et al., 1998; Xu et al., 2012). The dead time of the ultra-rapid mixer
was determined to be 56 ± 5 ms by measuring the quenching of N-acetyltryp-
tophanamide fluorescence by N-bromosuccinimide (Roder et al., 2004, 2006;
Xu et al., 2012). The fluorescence traces independently obtained using the
stopped-flow and ultra-rapid mixing apparatus were globally fitted to a single
or double exponential function with common values of the apparent rate con-
stants and kinetic amplitudes. The fluorescence intensities were normalized to
those measured under the initial conditions. Protein concentrations of 5 and
10 mM were utilized for the stopped-flow and ultra-rapid mixing measure-
ments, respectively.
The family of kinetic traces for folding/unfolding of the N- and A-states of
mouse PrP was modeled globally, assuming a four-state sequential scheme
(U4I4A4N). Elementary rate constants and kinetic m values obtained by
numeric solution of the differential equations describing this scheme (Xu
et al., 2012) are provided in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.str.2015.07.001.
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